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Abstract
Callipyge sheep exhibit extreme postnatal muscle hypertrophy in the loin and hindquarters as a result of a single nucleotide
polymorphism (SNP) in the imprinted DLK1-DIO3 domain on ovine chromosome 18. The callipyge SNP up-regulates the
expression of surrounding transcripts when inherited in cis without altering their allele-specific imprinting status. The
callipyge phenotype exhibits polar overdominant inheritance since only paternal heterozygous animals have muscle
hypertrophy. Two studies were conducted profiling gene expression in lamb muscles to determine the down-stream effects
of over-expression of paternal allele-specific DLK1 and RTL1 as well as maternal allele-specific MEG3, RTL1AS and MEG8, using
Affymetrix bovine expression arrays. A total of 375 transcripts were differentially expressed in callipyge muscle and 25
transcripts were subsequently validated by quantitative PCR. The muscle-specific expression patterns of most genes were
similar to DLK1 and included genes that are transcriptional repressors or affect feedback mechanisms in b-adrenergic and
growth factor signaling pathways. One gene, phosphodiesterase 7A had an expression pattern similar to RTL1 expression
indicating a biological activity for RTL1 in muscle. Only transcripts that localize to the DLK1-DIO3 domain were affected by
inheritance of a maternal callipyge allele. Callipyge sheep are a unique model to study over expression of both paternal
allele-specific genes and maternal allele-specific non-coding RNA with an accessible and nonlethal phenotype. This study
has identified a number of genes that are regulated by DLK1 and RTL1 expression and exert control on postnatal skeletal
muscle growth. The genes identified in this model are primary candidates for naturally regulating postnatal muscle growth
in all meat animal species, and may serve as targets to ameliorate muscle atrophy conditions including myopathic diseases
and age-related sarcopenia.
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Introduction
Callipyge sheep are a well recognized model for muscle growth
and polar overdominant inheritance. Callipyge animals exhibit a
30–40% increase in postnatal muscle growth of the pelvic and loin
muscles as well as a 6–7% decrease in total fat content [1–5]. The
muscle hypertrophy phenotype is the result of an increase in both
the size and proportion of type IIB glycolytic myofibers, while the
total number of myofibers is not affected [6–8].
The callipyge mutation (C) is a single nucleotide polymorphism
that is located in an intergenic region between Delta-like homologue 1
(DLK1) and Maternal Expressed Gene 3 (MEG3) in the DLK1-DIO3
imprinted domain on ovine chromosome 18 (Figure 1) [9–11].
The callipyge phenotype was the first demonstration of polar
overdominance in mammals [12,13]. Paternal heterozygous (+/
C
Pat) lambs exhibit the callipyge phenotype of muscle hypertrophy,
but maternal heterozygous (C
Mat/+) and homozygous (C/C) lambs
have muscle growth equivalent to normal (+/+) lambs [12,13].
There has been evidence for polar overdominance effects of the
orthologous DLK1/MEG3 region on birth weight, weaning weight,
and average daily gain in pigs [14,15] and childhood obesity in
humans [16].
The callipyge mutation has altered a putative long range control
element [17] but has not altered the parent-of-origin allele-specific
expression [10]. In all hypertrophied muscles of callipyge sheep (+/
C
Pat)thathave beenexaminedtodate,thereiselevatedexpression of
both paternal allele-specific protein coding genes, DLK1 and
Retrotransposon-like 1 (RTL1; Figure 1), making it ambiguous as to
which gene causes muscle hypertrophy [10,18–21]. Transgenic
mice over-expressing DLK1 in skeletal muscle had a significant
increase in muscle mass and muscle fiber size compared to normal
mice and this study concluded that DLK1 was the cause of muscle
hypertrophy in callipyge sheep [22]. Animals possessing a
maternally inherited callipyge allele (C
Mat/+ and C/C) show up-
regulation of the maternally expressed non-coding RNA transcripts
(Figure 1): RTL1-antisense (RTL1AS), MEG3 and Maternally Expressed
Gene 8 (MEG8) in skeletal muscle [10,18,20,21,23]. Homozygous
(C/C) animals exhibit a cis effect of the mutation on both the
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allele specific genes are expressed at a lower level than in callipyge
(+/C
Pat) lambs [10,18]. This led to the hypothesis of a trans-
interaction between the products of the maternal and paternal
alleles to create the polar overdominant inheritance of the callipyge
phenotype [17]. Four microRNA have been detected in longissimus
dorsi of C/C animals from the maternal transcript, RTL1AS, along
with their cleavage products from the paternal RTL1 transcript,
demonstrating a trans-interaction of the alleles in sheep [24]. This
result suggests that RTL1/RTL1AS expression is responsible for
polar overdominance and the biological activities of both genes
contribute to muscle hypertrophy.
DLK1 is widely expressed in many tissues during mammalian
embryonic development [25–27] and is implicated as an important
developmental growth factor. The glycoprotein has six EGF-like
repeats in an extracellular domain and a transmembrane domain
[28]. The circulating cleavage product was shown to be identical
to fetal antigen 1, found in the serum of pregnant females and in
amniotic fluid [28,29]. Splice variants of DLK1 have in-frame
deletions of the sixth EGF repeat and parts of the juxtamembrane
domain and those translation products remain membrane
associated [30,31]. A membrane bound splice variant of DLK1
appears to be the predominant transcript in sheep muscle [22].
The DLK1 protein was highly abundant in the endomycium
surrounding individual myofibers and the perimycium separating
fiber bundles of hypertrophied callipyge muscles [8].
RTL1, also known as PEG11, has evolved from an ancestral
gypsy LTR- retrotransposon insertion prior to the divergence of
marsupials and placental mammals and has gained function in the
mammalian genome [32,33]. A placental function for the RTL1
gene has been determined by gene targeting in mice to generate
both RTL1 knock-out and over-expression due to the loss of
RTL1AS microRNA [34]. Both models showed developmental and
growth changes related to the fetal-maternal interface of the
placenta. Histological analysis showed abnormalities in the
endothelial cells of the fetal capillaries at the maternal-fetal
interface and the RTL1 protein was localized in the perinuclear
areas of the endothelial cells [34].
All of the maternal allele-specific transcripts produce non-
coding RNA. MEG3 is expressed in many tissues during
development including the central nervous system and most
mesoderm derived tissues where it is co-expressed with DLK1 [26].
Thirteen splice variants of MEG3 exist in mouse embryos [35] and
at least five mRNA variants have been detected in sheep skeletal
muscle [36]. The MEG8 gene is conserved between sheep and
humans and four exons of the 59 end of the MEG8 gene were
present in the ovine contig sequence (AF354168) [37]. One C/D
snoRNA precursor was detected in an intron of the human and
ovine genes and the human gene was predicted to host two
additional clusters of C/D snoRNA precursors in the introns of
MEG8 (Fig. 1) [38]. The Rian gene (RNA imprinted and
accumulating in nucleus) in the mouse was found in a similar
location as MEG8 and hosts nine C/D snoRNA but has little
sequence similarity [38,39].
The DLK1-DIO3 domain contains the largest known microRNA
cluster and has been detected in silico in all mammals with a
complete genome sequence (Fig. 1) [40–43]. The microRNA genes
were found as single genes and as tandem arrays in mouse and
human [40,41]. They are expressed from the maternal allele in the
mouse embryo (head, body and placenta) but expression in the
adult is restricted to the brain [41]. In the mouse, it has been
suggested that there is a long maternal allele-specific transcript
originating from MEG3/Gtl2 gene through the microRNA
containing gene (Mirg) [39] or there may be a series of overlapping
transcripts [44]. The ovine genome sequence is not available for
this region but many of these C/D snoRNA and microRNA genes
are annotated in the bovine genome sequence and several of these
microRNA have been detected by sequencing [45].
The purpose of this study was to identify downstream targets
and pathways responding to the over-expression of paternal allele-
specific and maternal allele-specific genes due to the callipyge
mutation. We have used the Affymetrix Bovine Expression Array
due to the high degree of similarity of ovine and bovine gene
sequences [46] and the availability of the bovine genome sequence
and annotation. We were making the assumption that the
microarray probes detect the orthologous ovine transcript and
previous results indicate that this was the case [47,48]. The effects
of up-regulation of DLK1 and RTL1 were measured by comparing
callipyge (+/C
Pat) to wild-type (+/+) muscles at three ages during
the initial development of muscle hypertrophy and one age after
hypertrophy was well established. The effects of the maternal
transcripts MEG3, MEG8 and their associated small RNA on
muscle gene expression were determined at a single age by
comparing C
Mat/+ and C/C expression profiles to +/C
Pat and +/+
expression profiles.
Two previous studies have been published on gene expression in
the longissimus dorsi of callipyge sheep by our group and our
collaborators [47,48]. The current study extends our knowledge by
profiling the semimembranosus, which has the largest magnitude of
hypertrophy [2,3,5] and uses a more extensive postnatal
developmental series. Differences in gene expression profiles
between the two muscles could be expected due to different
locations, functions, and fiber type proportions of the normal
muscles, but transcripts that are directly influenced by DLK1 or
Figure 1. Organization of the DLK1-DIO3 gene cluster in mammals. The relative positions of the maternal non-coding RNA genes and paternal
protein coding genes are based on the bovine chromosome 21 sequence contig NW_001494068. The genes are shaded black on the parent-of-origin
chromosome to indicate their allele-specific expression. The protein coding genes are expressed from the paternal allele (pat) and the non-coding
RNA are expressed from the maternal allele (mat). The causative mutation (SNP
CLPG) for the callipyge phenotype lies in the intergenic region between
DLK1 and MEG3. The black diamond indicates the approximate position of Affymetrix probe Bt18078.1.S1_at. The presence of C/D snoRNA and most
miRNA have been detected in the bovine genome sequence but have not been confirmed in sheep.
doi:10.1371/journal.pone.0007399.g001
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muscles. A subset of the genes were tested for differential gene
expression by quantitative PCR in two muscles that become
hypertrophied, the longissimus dorsi and semimembranosus, and one
muscle that does not hypertrophy, the supraspinatus, in a larger set
of callipyge sheep with known phenotypic data. The spatial and
temporal patterns of gene expression will allow us to discern some
direct transcriptional responses to DLK1 and RTL1 from
secondary and tertiary changes in expression due to the muscle
hypertrophy.
Results
Phenotypic data for muscle weights of animals sampled for this
experiment (Figure 2) show the characteristic muscle hypertrophy
responses that have been previously reported for callipyge lambs
[1–3]. The regression analysis of muscle weights on live weights
show that callipyge (+/C
Pat) longissimus dorsi (Fig. 2A) and
semimembranosus (Fig. 2B) grew at a faster rate than normal (+/+)
lambs after birth (P,0.0001 for both). The supraspinatus (Fig. 2C)
regression shows no effect of genotype (P=0.6999) at any live
weight, making the supraspinatus an appropriate non-hypertrophied
control muscle for the gene expression experiments. Furthermore,
the intercept values for all three muscles were not significantly
different between callipyge and normal animals indicating that the
callipyge lambs have normal muscle development at birth and
hypertrophy develops postnatally.
One objective was to identify the early transcriptional changes
that lead to muscle hypertrophy, so three of the four ages used for
microarray analysis (10, 20 and 30 days of age) are prior to
sufficient protein accretion (4–18 kg live weight) for muscle
weights of callipyge lambs to be statistically heavier than normal
lambs. Therefore, cross sectional areas of fast and slow twitch
myofibers were measured in the semimembranosus muscle of 20 and
30 day old lambs as a more sensitive measure of the onset of
muscle hypertrophy. Cross sectional areas and the proportion of
fast and slow twitch myofibers were analyzed for the effect of age
and genotype. There were no significant effects of age so the
results shown (Fig. 3) were pooled from both ages. Callipyge (+/
C
Pat) lambs exhibited larger cross sectional areas of fast twitch
fibers (P=0.0009), which were on average 72% larger than
normal (+/+) counterparts. The proportion of slow twitch fibers
were not different (P=0.2259) between genotypes but there was a
trend for cross sectional area of slow twitch fibers (P=0.0804) to
be larger in callipyge lambs at these ages (Figure 3). The
phenotypic data demonstrate that the process of hypertrophy
had begun at these young ages and the complete sample collection
is appropriate for microarray analysis and quantitative PCR
validation of transcriptional changes that result in muscle
hypertrophy.
Paternal Callipyge Allele Study
This experiment compared gene expression in the callipyge (+/
C
Pat) and normal (+/+) genotypes over a developmental time
course of four postnatal ages (10, 20, 30 and 80 D). Microarray
analysis of the semimembranosus RNA (n=16) on the bovine
Affymetrix GeneChip produced signals from 16,369 probe sets
that correspond to 16,034 Unigene transcripts. The Robust Multi-
array Average (RMA) algorithm [49] identified 375 probe sets that
were influenced by genotype (+/C
Pat vs. +/+) and 111 probe sets
with a significant effect of age at a False Discovery Rate
(FDR),0.10. Supplementary Table S1 provides the complete list
of Affymetrix probe sets and gene identifications available from the
NetAffx Analysis Center (Affymetrix Annotation Release 28
Figure 2. Muscle weight changes in callipyge (+/C) and normal
(+/+) lambs. Muscle weights were regressed on live weight for the
longissimus dorsi (A), semimembranosus (B) and supraspinatus (C).
Equations are given for each muscle and genotype with an asterisk
indicating statistical significance (P,.0001) in slopes and overall
equations. There were no effects of genotype on the intercepts of
any regression lines. The longissimus dorsi and semimembranosus
muscles of callipyge lambs grew at a faster rate that normal lambs,
but growth of the supraspinatus was not affected by genotype.
doi:10.1371/journal.pone.0007399.g002
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interactions. Based on the transformed and normalized mean
expression values for callipyge and normal genotypes, 212 probe
sets (57%) had higher transcript abundance and 163 (43%) had
lower transcript abundance in callipyge (+/C
Pat) muscle relative to
normal (+/+) muscle. The 375 Affymetrix probe sets produced 199
genes with functional annotations from the DAVID Knowledge-
base using the gene conversion tool [50]. This data set was
analyzed with the Functional Annotation Clustering tool in
DAVID [51,52] against the DAVID bovine background gene set
which clustered between 113–139 genes into 48 functional groups
(Supplementary Table S2). A summary of the gene ontology terms
and their associated probe sets that were enriched by 2-fold or
greater are shown in Table 1. This table is a summary of terms as
the biological process and molecular function categories had many
gene ontology terms that contained the same sets of genes with
similar levels of enrichment. The summary shows enrichment of
genes involved in respiration, glucose, lipid and energy metabolism
as well as myosin contractile complexes, motor activity and kinase
activity. Several functional clusters had distinct trends with respect
to the callipyge genotype, revealing how several cellular systems
are changing during muscle hypertrophy. All genes that have an
electron transport function were decreased in callipyge muscle, as
were the transcripts associated with the TCA cycle. Mitochondrial
related transcripts and transcripts with oxidation-reduction activity
were also decreased in callipyge muscle compared to wild-type.
Functional groups of genes that were up-regulated in callipyge
lambs included kinases, apoptotic factors, and glycolytic enzymes.
Quantitative PCR was used to verify differential gene
expression between callipyge (+/C
Pat) and normal lambs (+/+)
on a larger sample collection that included the individuals used for
the microarray analysis as well as additional lambs (biological
replicates) and additional ages from prenatal to 150 days of age.
Comparison of the current data set with published results
indicated a number of previously known differentially expressed
genes [47,48] with FDR values greater than 0.05 (ATF4,
COQ10A and HIPK2 with FDR=0.0615, 0.1033 and 0.2177,
respectively), therefore, we selected transcripts across a range of
FDR values. The 49 probe sets that were tested by quantitative
PCR are given in Table 2 along with their FDR values, gene
symbols, descriptions and public database identifiers. Overall,
51% (25 of 49) of the transcripts had significant (P,.05)
differential expression between genotypes by quantitative PCR.
For probe sets with a FDR value of less than 0.01 or 0.05,
differential gene expression between genotypes was verified for
70.5% (12 of 17) and 51.2% (20 of 39) of the transcripts,
respectively (Table 2). Figure 4 shows the relative expression levels
based on RMA interpretation of the 25 verified transcripts along
with a hierarchical clustering of these transcripts. Sixteen of the
transcripts had higher abundance in callipyge (+/C
Pat) muscle and
9 transcripts had higher abundance in normal (+/+) muscle.
Transcripts that were verified to be differentially expressed in
semimembranosus were subsequently tested in longissimus dorsi and
supraspinatus muscle samples. No further quantitative PCR analysis
was conducted if differential expression of transcripts identified in
this study were not verified in the semimembranosus RNA. The
complete summary of quantitative PCR statistics for the main
effects of genotype and age as well as the genotype by age
interaction in all three muscles are given in Supplementary Table
S3. Quantitative PCR data for transcript abundance (least square
means and standard errors) in the semimembranosus and supraspinatus
can be found in Supplementary Tables S4 and S5, respectively.
Several studies have demonstrated that DLK1 and RTL1 are
highly up-regulated in the hypertrophied muscles of callipyge (+/
C
Pat) sheep [18–20,47]. The microarray analyses (Fig. 4) and
quantitative PCR results confirmed a significantly higher tran-
script abundance of DLK1 (P,.0001) in the semimembranosus
(Fig. 5A) and longissimus dorsi (Supplementary Table S1) of callipyge
(+/C
Pat) lambs relative to normal (+/+) lambs. There was no effect
of genotype (P=.5711) on the expression of DLK1 in the
supraspinatus (Fig. 5B). Figure 5 shows developmental gene
expression data for three genes that have similar expression
profiles to DLK1. Two of these transcripts, PDE4D (Fig. 5C and D)
and PARK7 (Fig. 5E and F), had significantly increased transcript
abundance in the semimembranosus and longissimus dorsi of callipyge
(+/C
Pat) lambs but no significant differences in the supraspinatus.
Ten other verified genes had a similar expression pattern including
COQ10A, DNTTIP1, HDAC9, HIPK2, LOC513822, MAPK6,
MEG3, PFKM, RSPRY1 and SLC22A3 (Table 2, Supplementary
Table S3). Four verified transcripts were significantly down-
regulated in the semimembranosus and longissimus dorsi of callipyge (+/
C
Pat) lambs relative to normal (+/+) lambs but no effect of
genotype was detected in the supraspinatus. These genes included
BHLHB3 (Fig. 5G and H), AKR1C4, CDO1, IDH2 and LPL
(Table 2, Supplementary Table S3).
Probe sets for RTL1 were not represented on the bovine
Affymetrix GeneChip but quantitative PCR analysis showed
significant up-regulation of RTL1 (P,.0001) in the semimembranosus
and supraspinatus (Fig. 6A and B) consistent with previous results
[18,20]. Elevated levels of RTL1 expression have been demon-
strated in the longissimus dorsi of callipyge (+/C
Pat) lambs [18] but
was not verified for this study. One transcript, PDE7A, was
significantly up-regulated in the semimembranosus, longissimus dorsi
(P,.0001 for both), and the supraspinatus (P=0.0389) of callipyge
Figure 3. Myofiber area of semimembranosus muscles in
callipyge and normal lambs. Cross sectional areas of fast and slow
twitch myofibers of 20–30 day old callipyge and normal lambs are
shown. Differing lower case letters indicate significance between
genotypes (P=0.0009). There was a trend (P=0.0804) for the area of
slow twitch fibers to be larger in callipyge lambs. These results
indicated hypertrophic growth had begun in callipyge lambs at these
ages.
doi:10.1371/journal.pone.0007399.g003
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Pat) animals (Fig. 6C and D) suggesting that PDE7A may be a
down-stream target of RTL1 in skeletal muscle. Two additional
genes, APOD and KCNN3 were also significantly more abundant in
semimembranosus and longissimus dorsi but had a trend for differential
expression (P=0.0718 and 0.0994, respectively) in the supraspinatus
(Supplementary Table S3).
Five other transcripts that were validated by quantitative PCR
were only differentially expressed in one of the hypertrophied
muscles indicating that they are indirect and muscle-specific
responses to DLK1 or RTL1. The transcript abundance of FCGRT
and TXNIP were significantly down regulated (P=0.0228 and
0.0002, respectively) in the semimembranosus of callipyge (+/C
Pat)
lambs but was not differentially expressed in the longissimus dorsi or
supraspinatus (Supplementary Table S3). Transcripts for ATF4 and
RPS6K have been shown to be differentially expressed in the
longissimus dorsi [47,48] which was verified in this study but the two
transcripts showed no effect of genotype in the semimembranosus or
supraspinatus (Supplementary Table S3).
Maternal Callipyge Allele Influence
In the microarray experiment contrasting all four possible
genotypes, nine transcripts were detected as differentially ex-
pressed in animals possessing a maternal callipyge allele (C
Mat/+
and/or C/C). However upon quantitative PCR validation of all
nine transcripts, only three exhibited a significant change in
expression over several ages (Supplementary Tables S6 and S7).
The PARK7 transcript was differentially expressed in the C/C -
C
Pat/+ contrast, however this transcript was also differentially
Table 1. Summary of functional annotation clusters for the effect of genotype.
Category
Total
Genes
1 GO Term Description Count
Fold
Enrichment
Benjamini
FDR Probe Set ID
Cellular Component 113 016459 myosin complex 3 5.1 0.9801 Bt.1905.1.S1_at, Bt.4867.2.S1_at,
Bt.12300.2.S1_at
031980 mitochondrial lumen 8 3.1 0.5784 Bt.5966.1.A1_at, Bt.16082.1.S1_at,
Bt.5108.1.S1_at, Bt.5161.1.S1_at,
Bt.21849.1.S1_at, Bt.4555.1.S1_at,
Bt.28162.1.S1_at, Bt.28162.2.A1_at,
Bt.460.1.S1_s_at
Biological Process 121 045333 cellular respiration 4 5.2 0.9796 Bt.13324.2.S1_a_at, Bt.5520.1.S1_at,
Bt.23357.1.S1_at, Bt.13128.1.S1_at,
006094 gluconeogenesis 3 5.1 0.9999 Bt.562.1.S1_at, Bt.13505.1.S1_at,
Bt.19161.1.S1_at,
006006 glucose metabolic
process
8 5.1 0.1762 Bt.23217.1.S1_at, Bt.25555.1.S1_at,
Bt.3005.1.S1_at, Bt.562.1.S1_at,
Bt.22169.1.S1_at, Bt.23399.1.S1_at,
Bt.13505.1.S1_at, Bt.19161.1.S1_at
032787 monocarboxylic acid
metabolic process
13 4.3 0.0243 Bt.21113.1.S1_a_at, Bt.136.1.S1_at,
Bt.562.1.S1_at, Bt.23607.1.S1_at,
Bt.21584.1.S1_at, Bt.7215.1.S1_at,
Bt.5520.1.S1_at, Bt.13505.1.S1_at,
Bt.5966.1.A1_at, Bt.13324.2.S1_a_at,
Bt.23094.4.S1_at, Bt.21849.1.S1_at,
Bt.19161.1.S1_at
009057 macromolecule
catabolic process
9 2.6 0.9407 Bt.23217.1.S1_at, Bt.25555.1.S1_at,
Bt.3005.1.S1_at, Bt.562.1.S1_at,
Bt.22169.1.S1_at, Bt.23399.1.S1_at,
Bt.13505.1.S1_at, Bt.15972.1.S1_at,
Bt.5408.1.A1_at
009790 embryonic
development
4 2.3 1.0000 Bt.1151.1.S1_at, Bt.3730.1.S1_at,
Bt.15972.1.S1_at, Bt.5226.1.S1_at
Molecular Function 139 003995 acyl-CoA
dehydrogenase activity
3 8.4 0.9988 Bt.5966.1.A1_at, Bt.21849.1.S1_at,
Bt.7215.1.S1_at
016298 lipase activity 3 5.2 0.9997 Bt.5387.1.S1_at, Bt.448.1.S1_at,
Bt.5223.1.S1_at
050660 FAD binding 4 3.6 0.9993 Bt.5966.1.A1_at, Bt.21849.1.S1_at,
Bt.7215.1.S1_at, Bt.4008.1.S1_at
003774 motor activity 3 2.4 1.0000 Bt.1905.1.S1_at, Bt.4867.2.S1_at,
Bt.12300.2.S1_at
008234 cysteine-type peptidase
activity
3 2.3 1.0000 Bt.13730.1.A1_at, Bt.13730.2.S1_at,
Bt.393.1.S1_at, Bt.5408.1.A1_at
004674 protein serine/threonine
kinase activity
7 2.1 0.9997 Bt.17952.1.A1_at, Bt.120.1.S1_at,
Bt.19447.1.A1_at, Bt.1.1.S1_at,
Bt.4532.1.S1_at, Bt.4532.1.S2_at,
Bt.7105.1.S1_at, Bt.8706.1.S1_at,
Bt.22106.2.S1_at
1Number of genes out of the 375 genes with a significant effect of genotype that have GO term annotation for each category.
doi:10.1371/journal.pone.0007399.t001
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Pat vs +/+) so this was
interpreted to be an effect of the paternal callipyge allele in the
homozygous (C/C) animal. The other two transcripts, MEG3 and
CB439344, were both located within the DLK1-DIO3 domain.
The CB439344 transcript lies within a cluster of C/D snoRNA on
bovine chromosome 21 (Figure 1; maternal allele; black diamond)
which are found in the MEG8 gene of humans [38]. The
expression of CB439344 is nearly identical in magnitude and
pattern of response to the callipyge mutation compared to MEG8
as measured by quantitative PCR (Fig. 7). Muscle samples from
lambs of both genotypes possessing a maternal copy of the
callipyge allele (C
Mat/+ and C/C) express significantly higher levels
of both MEG8 and CB439344 (P,0.0001; Figure 7; Supplemen-
tary Table S6). The MEG8 and CB439344 transcripts were also
differentially expressed in the supraspinatus (Supplementary Table
S6) which has been previously demonstrated for MEG8 [20]. This
shows that CB439344 is directly influenced in cis by the callipyge
SNP that is 200 kb away and is consistent with the proposal that
MEG8 transcribes a very long non-coding RNA which includes the
C/D snoRNA in sheep.
One transcript, similar to selenophosphate synthetase 2 (SEPHS2),
was up-regulated in the C/C semimembranosus, but only at 30 days of
age. This result was confirmed by qPCR analysis. (data not shown).
Thus, the overall effect of genotype was non-significant across all ages
as measured by qPCR. No other significant effect of the maternal
callipyge allele was detected (Supplementary Table S6).
Discussion
Callipyge sheep are a unique model for investigating the effects
of elevated expression of the paternal and maternal allele-specific
transcripts from the DLK1-DIO3 domain. All of the lambs in this
study were actively growing due to the normal neuronal,
hormonal, nutritional, and exercise stimuli present in young
animals. Callipyge lambs have normal muscle development at
birth and just prior to birth, no differences in DLK1 and RTL1
expression were detected [20]. One possibility is that mechanical
tension and nerve stimulation that occurs when lambs begin to
walk and run is the initiating stimulus for differential DLK1 and
RTL1 expression and the onset of muscle hypertrophy.
Table 2. Affymetrix probe sets that were validated by quantitative PCR.
Probe Set ID Genotype FDR
1 Entrez Gene ID
2 Gene Symbol Gene Description
Bt.23094.4.S1_at 0.0518 282138 782922 AKR1C4 LOC782922 aldo-keto reductase family 1, member C4
Bt.13975.1.S1_a_at 0.0377 613972 APOD apolipoprotein D
Bt.12583.1.A1_at 0.0329 613907 BHLHB3 basicHLH Class B3, DEC2, SHARP-1
Bt.22379.1.S1_at 0.0099 536925 CABC1 chaperone, ABC1 activity of bc1 complex homolog (S. pombe)
Bt.4738.1.S1_at 0.0076 281039 CAST calpastatin
Bt.2723.1.A1_at 0.0661 514462 CDO1 cysteine dioxygenase, type I
Bt.5223.1.S1_at 0.0014 281117 DLK1 delta-like 1 homolog (Drosophila)
Bt.8972.1.S1_at 0.0014 505524 DNTTIP1 deoxynucleotidyltransferase, terminal, interacting protein 1
Bt.1035.1.S1_a_at 0.0105 338062 FCGRT Fc fragment of IgG, receptor, transporter, alpha
Bt.17876.1.A1_at 0.0478 CK847416 HDAC9 similar to histone deacetylase 9
Bt.5520.1.S1_at 0.0218 327669 IDH2 isocitrate dehydrogenase 2 (NADP+), mitochondrial
Bt.26158.1.A1_at 0.0010 534180 KCNN3 potassium intermediate/small conductance calcium-activated channel, family N3
Bt.26750.1.S1_at
Bt.26750.2.A1_at
0.0099
0.0518
513822 LOC513822 hypothetical protein containing a methyltransferase domain
Bt.5387.1.S1_at 0.0046 280843 LPL lipoprotein lipase
Bt.3448.3.S1_at 0.0288 538094 MAPK6 mitogen-activated protein kinase 6
Bt.12510.1.S1_at 0.0038 CB464112 MEG3 maternal expressed gene 3, GTL2 variant D
Bt.21745.1.S1_at 0.0010 511268 PARK7 Parkinson disease (autosomal recessive, early onset) 7
Bt.20446.1.A1_at 0.0010 539556 PDE4D cAMP specific phosphodiesterase 4D
Bt.12327.1.S1_at 0.0046 506790 TXNIP thioredoxin interacting protein
Bt.14371.1.A1_at 0.0099 CK968244 SLC22A3 similar to solute carrier family 22 member 3
Bt.2347.3.S1_a_at 0.0187 506544 PFKM phosphofructokinase, muscle
Bt.19420.1.S1_at 0.0343 CB464927 PDE7A similar to phosphodiesterase 7A
Bt.9244.1.A1_at 0.0518 538571 RSPRY1 ring finger and SPRY domain containing 1
Bt.27381.1.S1_at 0.1033 538821 COQ10A coenzyme Q10 homolog A (S. cerevisiae)
Bt.6890.1.S1_at 0.2177 CB439427 HIPK2 homeodomain interacting protein kinase 2
Bt.12510.1.S1_at
3 0.0016
4 CB464112 MEG3 maternal expressed gene 3/gene trap locus 2 variant D
Bt.18078.1.S1_at
3 0.0829
4 CB439344 MEG8 maternal expressed gene 8
1Genotype FDR from the microarray analysis. Statistics for all genes tested by quantitative PCR are given in Supplementary Table S1 (paternal allele study) and
Supplementary Table S4 (maternal allele study).
2Most representative public sequence identification is given if no Entrez gene ID was available.
3Probe sets that were validated from the maternal allele genotype comparisons.
4FDR value shown was for C
Mat/+ - +/+ comparison.
doi:10.1371/journal.pone.0007399.t002
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categorized as the primary causative genes, DLK1 and RTL1,
which are known due to the inheritance model, the secondary
effector genes that have a direct transcriptional response to DLK1
and RTL1 activities and the tertiary responses associated with
hypertrophy such as protein accretion, myofiber type and
metabolic changes. The mechanisms by which elevated DLK1
and RTL1 protein levels initially induce changes in gene
expression are not likely to be detected by RNA analysis but the
changes in transcript abundance of the secondary and tertiary
genes can be collectively identified by gene expression profiling.
This study of the semimembranosus muscle, along with our previous
analysis in the longissimus dorsi muscle [47], focused the majority of
the microarray analysis on early muscle hypertrophy (10, 20, and
30 days) in an effort to be sure to identify the secondary effector
genes that respond to DLK1 and/or RTL1 expression. Our initial
analysis of the onset of muscle hypertrophy in the longissimus dorsi
(10, 20 and 30 days) identified 13 probe sets with an effect of
genotype [47]. Our results in the longissimus dorsi and semimembra-
nosus (current study) indicate that changes in gene expression and
phenotype have begun at these ages. One older time point, 80
days of age, was included for well-established hypertrophy in the
current study and the broadest inclusion of the tertiary responses.
Inclusion of this older age as well as the use of different image
interpretation algorithms (MAS5 versus RMA) may account for
the large increase to 375 probe sets with a significant effect of
genotype.
A quantitative PCR validation strategy using a larger data set
and three muscles was used to help define secondary and tertiary
responses in hypertrophy. We are making the assumption that
changes in transcript abundance will correspond to altered protein
expression and biological activity, however, we recognize that will
not be true for all genes.
Comparisons of the microarray results from Fleming-Waddell
et al, [47]and the current results show an overlap of 8 transcripts
affected by genotype (DLK1, DNTTIP1, LOC513822, COQ10A,
PDE7A, PFKM, RSPRY1, and RPS6KA3) in both muscles. Seven of
the transcripts were verified to be differentially expressed in the
longissimus dorsi and semimembranosus by quantitative PCR with the
exception being RPS6KA3, where differential expression was only
verified in the longissimus dorsi. Another analysis of gene expression
in the longissimus dorsi of callipyge sheep examined neonatal animals
(less than 5 days of age) and 80 days when muscle hypertrophy has
been well established [48]. This study used technical replicates of
pooled RNA from different animals and analyzed differences
between genotypes at each age as well as contrasts of normal
muscles with different fiber type compositions. All three studies
produce different but overlapping groups of genes that are
influenced by the callipyge genotype and provide new insights
into the potential mechanism of DLK1 and RTL1 to alter skeletal
muscle growth.
The predominant changes in gene expression identified by
cluster analysis were metabolic biological processes as well as
changes in the mitochondria and myosin complex. This result was
greatly influenced by the state of annotation of the transcripts for
the cattle as only 199 of 375 probe sets had sufficient annotation
for cluster analysis by DAVID. Included in these metabolic genes
are two key rate-limiting allosteric enzymes. The enzyme isocitrate
dehydrogenase 2 (IDH2) catalyzes the first oxidation-reduction
step in the citric acid cycle. This is a key component in the
Figure 4. Hierarchal clustering and microarray signal intensity for genes validating an effect of genotype by quantitative PCR. Gene
names are listed for rows and columns are fixed for age in days and genotype (+/C for callipyge and +/+ for normal). Relationship amongst genes sets
was determined by hierarchal clustering in the heatmap.2 function of Bioconductor. Relative intensity by RMA is represented by green if expression
was higher than average or red if expression was lower than average.
doi:10.1371/journal.pone.0007399.g004
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PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7399Figure 5. Candiate genes with an expression pattern resembling DLK1. Least square means and standard errors for log transcript abundance
in 100 ng of total RNA in a hypertrophied muscle (semimembranosus, A, C, E, G) and a non-hypertrophied muscle (supraspinatus,B ,D ,F ,H )i n
callipyge (+/C) and wild-type (+/+) lambs. Birth is day 0 and samples from 14 days prepartum are included and represented as -14 days. DLK1
expression is shown in A and B. Transcripts PDE4D (C and D), PARK7 (E and F) and BHLHB3 (G and H) show a significant effect of the callipyge
genotype in semimembranosus, while no effect is observed in the supraspinatus. This pattern of expression suggests these genes are responding to
DLK1 signaling in callipyge muscle.
doi:10.1371/journal.pone.0007399.g005
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in callipyge hypertrophied muscles. In contrast, muscle phospho-
fructokinase (PFKM) is the first committed rate limiting step for
glycolysis. PFKM expression is highly up-regulated in callipyge
skeletal muscle. The expression profile of these two enzymes
confirms a shift from oxidative phosphorylation to glycolysis in the
muscle as a result of increasing the proportion of type IIB
glycolytic myofibers in callipyge sheep [53,54]. The differences
observed in these metabolic transcripts are likely tertiary effects of
the fiber type change.
Several candidate genes in our list of validated transcripts
suggest that callipyge muscle hypertrophy may be the result of a
loss of repression or reduction in a negative feedback mechanism
for controlling normal growth signals. Our data suggest that the
secondary effector genes may be nuclear regulatory factors
(chromatin modifiers, transcription factors or transcription acces-
sory factors) and components of signal transduction pathways.
Two known transcriptional repressors of myogenesis, HDAC9
and BHLHB3 (also known as SHARP1; DEC2) were down-
regulated in callipyge muscle. The role of HDAC9 in the feedback
inhibition of myogenic differentiation has been described [55] and
a model for the mechanism of DLK1 inhibition of HDAC9 in
callipyge muscle has been proposed [48]. BHLHB3 is a
transcriptional repressor of genes containing E-box elements
[56-60] and along with BHLHB2 (also known as SHARP2;
DEC1) are members of a fifth circadian clock gene family
[61,62]. BHLHB3 is in the same family of class B3 proteins as
HES-1, a downstream target of Notch-1 activation which also
inhibits the myogenic regulatory factor, MyoD [63–65]. Specifi-
cally in muscle, BHLHB3 exhibits negative regulation of MyoD
activation of myogenin transcription in skeletal muscle [66]. Lower
levels of BHLHB3 in callipyge muscle would promote the rate of
fusion of individual myoblasts into mature myofibers [67]. DLK1
is thought to act as a ligand for Notch-1 [68] and has been shown
to antagonize Notch-1 activity [68–70]. Down-regulation of
BHLHB3 may be an early indicator of suppression of Notch-1
signaling in callipyge muscle. The chromosomal region on bovine
chromosome 5 that contains BHLHB3 also contains several
significant quantitative trait loci (QTL) for muscle growth
including dressing percentage and longissimus dorsi rib eye area [71].
Several transcripts that were confirmed as differentially
expressed between callipyge (+/C
Pat) and normal (+/+) muscles
have regulatory roles in the b-adrenergic or mTOR/AKT
signaling pathways that control postnatal muscle growth. Two
phosphodiesterase transcripts, PDE7A and PDE4D, were validated
by quantitative PCR and a third, PDE8A was identified by
Figure 6. PDE7A exhibits an expression pattern resembling RTL1. Least square means and standard errors for log transcript abundance in
100 ng of total RNA in a hypertrophied muscle (semimembranosus, A and C) and an unaffected muscle (supraspinatus, B and D) in callipyge (+/C) and
wild-type (+/+) lambs. Birth is day 0 and samples from 14 days prepartum are included and represented as -14 days. RTL1 expression is shown in A
and B and PDE7A expression is shown in C and D. Transcript abundance of RTL1 and PDE7A is up-regulated as a result of the callipyge allele in both
muscles, suggesting PDE7A may respond to RTL1 expression.
doi:10.1371/journal.pone.0007399.g006
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phosphodiesterases that hydrolyze cAMP into the inactive
substrate 59-AMP and therefore have a role in regulating the
duration and magnitude of cAMP second messenger activities
[72–74]. Both PDE7A and PDE4D are members of multi-gene
families and each produces a series of splice variants that
determine their subcellular location and compartmentalize their
effects on cAMP signaling. Identifying the specific variants that are
up-regulated and their localization in muscle will be essential to
determine their role in muscle hypertrophy.
PDE4D accounts for 80% of the phosphodiesterase activity in
skeletal muscle and plays a role in lipolysis rates [75]. Expression of
PDE4D was required for IGF-1 induced myogenic differentiation
in rat L6 myoblast cells [76]. PDE4D is a component of the b2-
adrenergic receptor signaling complex in cardiac muscle [77] and
has a role preventing the desensitization and down regulation of
the b2-adrenergic receptor [78,79]. The up-regulation of PDE4D
in callipyge muscle could prevent desensitization of the b2-
adrenergic receptor that would propagate a stronger response to
physiological levels of adrenaline in young growing lambs. The
phenotype observed in callipyge hypertrophy is very similar to
muscle growth induced by b-agonists, which includes an increase
in size and proportion of fast twitch myofibers and a decrease in
body fat content [80-82]. Callipyge sheep do not respond to b-
agonist supplementation with additional muscle hypertrophy [80].
PDE7A splice variants are expressed in many tissues and are
most abundant in skeletal muscle. Messenger RNA levels of
PDE7A are much higher than corresponding protein levels in the
same tissue, suggesting PDE7A is regulated at the post-transcrip-
tional and translational level [83]. The quantitative PCR
validation showed that PDE7A transcripts were up-regulated in
all three muscles including the supraspinatus which has only has
elevated levels of RTL1 and does not become hypertrophied. This
makes PDE7A a candidate to be a secondary effector gene since it
responds to RTL1 expression but is not confounded by muscle
hypertrophy. Two other transcripts, APOD and KCNN3, showed a
genotypic trend (P,0.10) for differential expression in the
supraspinatus as well. The up-regulation of PDE7A in the
supraspinatus is an indicator that RTL1 expression has a biological
activity in skeletal muscle and provides further evidence of its role
in the callipyge phenotype beyond the trans-interaction of RTL1
and RTL1AS microRNA as a mechanism of polar overdominance
[24].
The AKT/mTOR pathway has been shown to be an important
signal transduction pathway for regulating muscle growth [63,84–
88]. Two transcripts were validated by quantitative PCR, PARK7
and TXNIP, are components of a feedback mechanism controlling
AKT activation. Figure 8 shows a working hypothesis for how this
pathway may be affected in callipyge lambs. A variety of hormone
-receptor interactions, b-adrenergic, insulin or IGF-1 (IGF-1
depicted in Figure 8) stimulate the phosphoinositide-3-kinase
(PI3K) pathway to produce phosphatidylinositol (3,4,5) triphos-
phate (PIP3). PTEN (phosphatase and tensin homologue) is a 39
phosphatase that regulates the pool of PIP3 by catalyzing
dephosphorylation of PIP3 to phosphatidylinositol (3,4) diphos-
phate (PIP2). AKT (also known as protein kinase B) is recruited to
the membrane by PIP3 and activated via phosphorylation by
phosphoinositide-dependent kinase (PDK). Activated AKT can
phosphorylate a number of target proteins including mTOR
(mammalian target of rapamycin) which in turn activates p70
S6K
to increase protein synthesis [89].
The PARK7 protein, also known as DJ-1, has been shown to
negatively regulate the function of PTEN [90]. PARK7 was up-
regulated in both the semimembranosus and longissimus dorsi which
would result in less PTEN phosphatase activity and a higher level
or longer duration of AKT activation after growth factor
stimulation. Mouse models of constitutively active AKT induce
hypertrophy, specifically in the fast twitch Type IIB fibers of
skeletal muscles and cause a reduction in body fat similar to the
callipyge phenotype [87,88]
TXNIP was significantly decreased in callipyge semimembranosus
and is a negative regulator of protein synthesis. The TXNIP
protein reduces thioredoxin in the cell [91] which is necessary for
the reactivation of oxidized PTEN [92,93]. Therefore reduced
Figure 7. Expression of MEG8 and CB439344 in the semimem-
branosus influenced by the presence of a maternal callipyge
allele. Expression of MEG8 exons in all four possible callipyge
genotypes (A) is shown in comparison to expression of transcript
CB439344 (B) that maps to the C/D snoRNA clusters of MEG8 in cattle.
Lambs possessing a maternal callipyge allele (C/+ and C/C) exhibit
significantly higher levels of MEG8 expression and CB439344 than
callipyge (+/C) and normal lambs (+/+).
doi:10.1371/journal.pone.0007399.g007
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increase in the amount of PIP3 available to activate signaling in the
AKT/mTOR growth pathway [94]. TXNIP knock-out mice show
high levels of accumulated inactive PTEN with higher levels of
activated AKT resulting in more glycolytic oxidation in their
skeletal muscle [94]. Low endogenous levels of TXNIP expression
caused by genetic variation in pigs were correlated with heavier
carcass weights and faster rates of gain in commercial swine breeds
[95]. It should be noted that TXNIP expression levels were only
significantly decreased in callipyge semimembranosus, and not in the
longissimus dorsi indicating that this gene is a muscle specific tertiary
response. The altered expression of both PARK7 and TXNIP may
explain why semimembranosus muscle undergoes the greatest
magnitude of hypertrophy of all muscles in callipyge animals
[2,4,5].
Gene expression in the two genotypes that have a maternal
callipyge allele (C
Mat/+ and C/C) were compared to both callipyge
(+/C
Pat) and normal (+/+) semimembranosus to examine the effects of
over-expression of the maternal transcripts and their small RNA.
Microarray analysis identified differential expression of 9 tran-
scripts at a single age. However, only transcripts located within the
DLK1-DIO3 domain were verified by quantitative PCR to have a
significant effect of the maternal callipyge allele in animals from 14
days prenatal to 60 days of age. Notably, the transcript annotated
as CB439344 occurs nearly 90 kb downstream of the reported end
of the four MEG8 exons in sheep and cow. This transcript falls
within a region of C/D snoRNA that were identified in the human
MEG8 [38] and are present in the bovine genome sequence. Our
data extend the cis effect of the callipyge mutation into the C/D
snoRNA clusters hosted in MEG8 introns and support the
hypothesis of a long maternal RNA transcript [39] through this
region that could also include the microRNA cluster. The
sequence of these C/D snoRNA in humans were not similar to
other C/D snoRNA that are methylation guides for rRNA or U
snRNA and may have a function other than RNA modification
[38]. Target prediction of the microRNA from this domain in
mouse and human indicates that they would target a broad variety
of genes and not target a specific set of genes [42,44]. We find no
evidence that any genes expressed in semimembranosus and
detectable by the Affymetrix bovine microarray are affected by
these maternal allele specific transcripts. This does not rule out the
possibility that these genes may have roles in early embryonic
development or in the brain [39,42].
This work has identified several hundred transcripts that were
differentially expressed in the callipyge model and 25 genes have
been validated by quantitative PCR in a larger sample population.
Within this subset, we have identified changes in nuclear repressor
expression and feedback mechanisms in two major protein
accretion pathways, the b-adrenergic and AKT/mTOR, that
were altered in callipyge hypertrophied muscles. The callipyge
phenotype in sheep indicates that a significant potential for
increased muscle growth remains in livestock without increasing
feed intake or body size. The genes identified in this model are
primary candidates for naturally regulating postnatal muscle
growth in all meat animal species, and may serve as targets to
ameliorate muscle atrophy conditions including myopathic
diseases and age-related sarcopenia.
Materials and Methods
Ethics Statement
All animals were euthanized in a humane manner in
accordance with approved Purdue University or Utah State
University Animal Care and Use Committee protocols.
Sample Collection
Planned matings were conducted to produce all four possible
genotypes with respect to the callipyge allele. All lambs were
genotyped at the callipyge single nucleotide polymorphism
(Freking et al. 2002; Smit et al. 2003) and several microsatellite
Figure 8. Influence of PARK7 and TXNIP on AKT/mTOR signaling in callipyge muscle hypertrophy. The diagram depicts the AKT
response to IGF-1 signaling which increases protein synthesis. Two regulatory proteins of the AKT/mTOR pathway are differentially expressed in
callipyge hypertrophied muscles. Factors that are inhibitory of protein synthesis are indicated in red and stimulatory factors are green. Transcripts
that were down-regulated in callipyge (+/C
Pat) muscle are rectangles and transcripts that were up-regulated in callipyge muscle are cross shaped. In
this model, the phosphatase activity of PTEN is inhibited by PARK7 and TXNIP and the AKT/mTOR response to normal physiological levels of growth
factors is magnified to increase protein synthesis rates.
doi:10.1371/journal.pone.0007399.g008
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(+/C
Pat) and normal (+/+) lambs were sampled at 14 days prenatal
and 10, 20, 30, 45, 60, 80, 90,110, 130, and 150 days post-partum
with at least 3 animals per age and genotype combination for a
total of 45 callipyge and 43 normal sheep. At 70 days of age, lambs
were placed in individual pens to measure weekly weight gain and
ad libitum feed consumption. Maternal heterozygotes (C
Mat/+;
n=24) and homozygous (C/C; n=19) lambs were sampled at 14
days prenatal, and 20, 30, 45, and 60 days of age. Lambs were
weaned at 60 days of age and placed on a complete mixed ration
fed ad libitum.
Longissimus dorsi, semimembranosus, and supraspinatus were excised
and weighed. Semimembranosus samples were frozen in isopentane
chilled in liquid nitrogen and sectioned in a cryostat microtome for
immunofluorescence detection of fast and slow myofibers. The
sections were fixed, stained and measured for cross sectional area
using the methods previously described by White et al, [8].
Muscle samples were fixed in RNAlater storage solution
(Ambion Inc., Woodlands, TX, USA) immediately after collection.
Tissues were homogenized in 4 M guanidinium thiocyanate,
25 mM sodium citrate, 50 mM EDTA, 1% sodium-N-lauroyl-
sarcosine. RNA was isolated by ultracentrifugation of the tissue
homogenate on a cushion of 5.7 M CsCl, 50 mM EDTA, [96]
and then further purified and treated with DNase I using
NucleoSpin RNA II columns (Machery-Nagel Inc., Easton, PA,
USA).
Microarrays
RNA samples isolated from the semimembranosus muscles of two
callipyge and normal lambs at 10, 20, 30 and 80 days of age were
used for the paternal callipyge allele microarray experiment for a
total of 16 individuals. For the maternal callipyge allele
experiment, the semimembranosus of three maternal heterozygous
(C
Mat/+) and three homozygous (C/C) lambs at 30 days of age
were used to compare to the 30 day old callipyge (+/C
Pat) and
normal microarrays already obtained. Each RNA sample was
hybridized to a separate array, resulting in biological replicates for
each genotype and age combination. Five micrograms of skeletal
muscle total RNA were converted to biotinylated cRNA using the
manufacturer’s reagents and protocols (Affymetrix Inc., Santa
Clara, CA, USA). GeneChip poly-A control factors were included
in the cRNA synthesis and 20 mg of cRNA were fragmented and
hybridized to the Affymetrix Bovine Expression Array. Eukaryotic
hybridization controls and herring sperm DNA were added to the
hybridization mix and incubated for 16 h at 45uC. Chips were
then stained using streptavidin phycoerytherin. The arrays were
scanned using the GeneChip Scanner 3000 and GeneChip
Operating Software (GCOS, Affymetrix Inc.). All raw microarray
data were deposited in Gene Expression Omnibus (NCBI,
Bethesda, MD, USA) in accordance with MIAME compliance
(accession no. GSE11780).
Microarray Analysis
Affymetrix microarray images were interpreted by RMA [49],
using Bioconductor in R [97,98]. RMA values were directly placed
into the second stage of the model proposed by Wolfinger [99]
since RMA incorporates a transformation and normalization step.
The second stage fit a separate model for each gene, allowing each
gene its own variability estimate. The ANOVA performed in this
step was a mixed model with genotype, age and genotype6age
interaction as fixed effects and chip (nested within interaction) as a
random effect. Using the p-values obtained from the second stage
model for each gene, the Benjamini and Hochberg false discovery
rate method [100] was employed to identify genes with significant
differential expression between genotype, age, and their interac-
tion. All microarray data analyses were performed in SAS (SAS
Institute Inc., Cary, NC, USA).
The microarray analysis for the four genotype comparison used
the same steps for image interpretation and the first stage
normalization. An ANOVA was performed for the effect of
genotype with the following specific pair-wise contrasts: C/C vs. +/
C
Pat, C/C vs. C
Mat/+, and C
Mat/+ vs. +/+. Each contrast was
subjected to its own FDR correction, as described previously.
Quantitative RT-PCR
Primary annotations of probe set sequences were obtained from
the Affymetrix NetAffx Analysis Center. Probe set sequences were
also compared to the nonredundant Genbank database by BLAST
(NCBI, Bethesda, MD, USA) to confirm the current most
representative public ID and annotation for cattle. Transcripts
will be discussed by gene name if known, or by bovine locus
designation. All annotations and primer designs were performed
using bovine sequences. Primers were designed for quantitative
PCR (qPCR) from the most representative public ID sequence
using Oligo5.0 software (Molecular Biology Insights, Inc.,
Cascade, CO). All quantitative PCR assays were developed with
at least one primer contained within the probe set identity region
of the bovine transcript. Primer sequences and quantitative PCR
conditions are given in Supplemantary Table 8.
Complimentary DNA (cDNA) was synthesized and diluted
according the methods described previously [47]. Primer pairs for
qPCR analysis were tested on muscle cDNA from eight individuals
using iQ SYBR Green Supermix reagents on an iCycler Real-
Time PCR Detection System (Bio-Rad Inc., Hercules, CA, USA).
Primer specificity and capture temperature were determined by
melt curve analysis. PCR products were cloned into pCR-4TOPO
vector and chemically transformed into TOP10 E. coli (Invitrogen,
Inc). Plasmids were sequenced to confirm that the sheep ortholog
of each respective bovine transcript was amplified by the primers.
Plasmids with sequence-verified inserts were quantified by
fluorometry (PicogreenH dsDNA Quantitation Kit, Invitrogen,
Inc) and digested with EcoRI.
Quantitative PCR assays were carried out in 15 mL reaction
volumes of iQ SYBR Green Supermix with diluted first-strand
cDNA equivalent to 100 ng of input RNA. All cDNA samples
were assayed in duplicate. Primer sequences and thermal cycling
conditions are given in Supplemantary Table 8. Quantification
standards were comprised of four 100-fold dilutions of plasmid
DNA (10
8 to 10
2 or 10
7 to 10
1 molecules) and were assayed in
triplicate. Standards were used to calculate a linear regression
model for threshold cycle relative to transcript abundance in each
sample.
Log values for transcript abundance from each sample duplicate
were subjected to an ANOVA using the MIXED procedure of
SASH for genotype and age effects as well as the genotype6age
interaction. The random effect was defined as animal nested
within genotype6age. An alpha of 0.05 was used for all PCR
analysis and any significant interactions were parsed into genotype
effects at each individual age. Statistical p-values are shown in
Supplementary Tables S1 and S4.
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